Heme catabolism and heme oxygenase in neurodegenerative disease

Antioxidants and Redox Signaling

Volumn 6, Issue 5, 2004, Pages 888-894

  Takeda, Atsushi ^a   Itoyama, Yasuto ^a   Kimpara, Teiko ^b   Zhu, Xiongwei ^c   Avila, Jesús ^d   Dwyer, Barney E ^e   Perry, George ^c   Smith, Mark A ^c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOHNAN HOSPITAL   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e Department of Veterans Affairs Regional Office White River Junction   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; IRON; MITOGEN ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BRAIN; CARBOXY TERMINAL SEQUENCE; CATABOLISM; CELL PROTECTION; CONFORMATION; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; IRON METABOLISM; LIPID PEROXIDATION; NERVE CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

CARBON MONOXIDE; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; IRON; ISOENZYMES; MOLECULAR STRUCTURE; NEURODEGENERATIVE DISEASES; PROTEIN CONFORMATION; TAU PROTEINS;

EID: 4544273847     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2004.6.888     Document Type: Review

References (73)

1. Abraham NG, Lin JH, Schwartzman ML, Levere RD, and Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 20: 543-558, 1988.
2. Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, and Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci U S A 92: 6798-6802, 1995.
3. Barañano DE and Snyder SH. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A 98: 10996-11002, 2001.
4. Benzing WC, Ikonomovic MD, Brady DR, Mufson EJ, and Armstrong DM. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. J Comp Neurol 334: 176-191, 1993.
5. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, and Snyder SH. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40: 129-137, 2003.
6. Carmel G, Mager EM, Binder LI, and Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271: 32789-32795, 1996.
7. Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, and Perry G. Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res 696: 268-271, 1995.
8. Castellani RJ, Harris PLR, Lecroisey A, Izadi-Pruneyre N, Wandersman C, Perry G, and Smith MA. Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease. Antioxid Redox Signal 2: 137-142, 2000.
9. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
10. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, and Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693-698, 2001.
11. Ewing JF and Maines MD. Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain. J Neurochem 60: 1512-1519, 1993.
12. Fujita T, Toda K, Karimova A, Van SF, Naka Y, Yet SF, and Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7: 598-604, 2001.
13. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, and Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369: 488-491, 1994.
14. Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, and Sasaki H. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102: 1619-1621, 2003.
15. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, and Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023, 2001.
16. Jicha GA, Bowser R, Kazam IG, and Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48: 128-132, 1997.
17. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002.
18. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, and Shibahara S. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100: 145-147, 1997.
19. Kimpara T, Takeda A, Yamaguchi T, Arai H, Okita N, Takase S, Sasaki H, and Itoyama Y. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging 21: 551-554, 2000.
20. Liu X-M, Chapman GB, Peyton KJ, Schafer AI, and Durante W. Antiapoptotic action of carbon monoxide on cultured vascular smooth muscle cells. Exp Biol Med 228: 572-575, 2003.
21. Maines MD. The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46: 573-585, 2000.
22. Maines MD. Heme oxygenase 1 transgenic mice as a model to study neuroprotection. Methods Enzymol 353: 374-388, 2002.
23. Mattson MP, Robinson N, and Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8: 3817-3821, 1997.
24. McCoubrey WK Jr, Huang TJ, and Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725-732, 1997.
25. McShea A, Harris PLR, Webster KR, Wahl AF, and Smith MA. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol 150: 1933-1939, 1997.
26. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, and Smith MA. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19: 1959-1964, 1999.
27. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, and Smith MA. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome. J Neuropathol Exp Neurol 59: 1011-1017, 2000.
28. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, and Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767, 2001.
29. Ogawa O, Lee HG, Zhu X, Raina A, Harris PLR, Castellani RJ, Perry G, and Smith MA. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2: 105-110, 2003.
30. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, Ghanbari HA, Castellani RJ, Perry G, and Smith MA. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol 105: 524-528, 2003.
31. Okinaga S, Takahashi K, Takeda K, Yoshizawa M, Fujita H, Sasaki H, and Shibahara S. Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood 87: 5074-5084, 1996.
32. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
33. Perez M, Cuadros R, Smith MA, Perry G, and Avila J. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett 486: 270-274, 2000.
34. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PLR, and Smith MA. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10: 2411-2415, 1999.
35. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919-10924, 1997.
36. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930, 1997.
37. Premkumar DRD, Smith MA, Richey PL, Petersen RB, Castellani R, Kutty RK, Wiggert B, Perry G, and Kalaria RN. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65: 1399-1402, 1995.
38. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, and Smith MA. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61: 128-133, 2000.
39. Salinas M, Diaz R, Abraham NG, Ruiz de Galarreta CM, and Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 278: 13898-13904, 2003.
40. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, and Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68: 2092-2097, 1997.
41. Sayre LM, Perry G, Harris PLR, Liu Y, Schubert KA, and Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 74: 270-279, 2000.
42. Scapagnini G, D'Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, and Cavallaro S. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954: 51-59, 2002.
43. Schillinger M, Exner M, Mlekusch W, Domanovits H, Huber K, Mannhalter C, Wagner O, and Minar E. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 106: 131-136, 2002.
44. Schipper HM. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35: 821-830, 2000.
45. Schipper HM, Cisse S, and Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37: 758-768, 1995.
46. Schipper HM, Liberman A, and Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150: 60-68, 1998.
47. Shibahara S, Muller RM, and Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem 262: 12889-12892, 1987.
48. Shimizu S, Narita M, and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487, 1999.
49. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, and Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145: 42-47, 1994.
50. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, and Kowall N. Oxidative damage in Alzheimer's. Nature 382: 120-121, 1996.
51. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17: 2653-2657, 1997.
52. Smith MA, Harris PLR, Sayre LM, and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94: 9866-9868, 1997.
53. Smith MA, Wehr K, Harris PLR, Siedlak SL, Connor JR, and Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788: 232-236, 1998.
54. Smith MA, Nunomura A, Zhu X, Takeda A, and Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2: 413-420, 2000.
55. Smith MA, Casadesus G, Joseph JA, and Perry G. Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33: 1194-1199, 2002.
56. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J, Alber SM, Watkins SC, Zuckerbraun BS, Otterbein LE, Ning W, Oury TD, Lee PJ, McCurry KR, and Choi AMK. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 163: 231-242, 2003.
57. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
58. Takahashi M, Dore S, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia SS, and Snyder SH. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28: 461-473, 2000.
59. Takeda A, Onodera H, Sugimoto A, Itoyama Y, Kogure K, and Shibahara S. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 666: 120-124, 1994.
60. Takeda A, Kimpara T, Onodera H, Itoyama Y, Shibahara S, and Kogure K. Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci Lett 205: 169-172, 1996.
61. Takeda A, Smith MA, Avila J, Nunomura A, Siedlak SL, Zhu X, Perry G, and Sayre LM. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 75: 1234-1241, 2000.
62. Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen JT, Petersen RB, and Smith MA. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275: 5395-5399, 2000.
63. Trakshel GM, Kutty RK, and Maines MD. Resolution of the rat brain heme oxygenase activity: absence of a detectable amount of the inducible form (HO-1). Arch Biochem Biophys 260: 732-739, 1988.
64. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, and Snyder SH. Carbon monoxide: a putative neural messenger. Science 259: 381-384, 1993.
65. Watts RN, Ponka P, and Richardson DR. Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron. Biochem J 369: 429-440, 2003.
66. Wolozin BL, Pruchnicki A, Dickson DW, and Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 232: 648-650, 1986.
67. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
68. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, and Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66: 187-195, 2000.
69. Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, and Smith MA. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 59: 880-888, 2000.
70. Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, and Smith MA. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the "two hit" hypothesis. Mech Ageing Dev 123: 39-46, 2001.
71. Zhu X, Sun Z, Lee HG, Siedlak SL, Perry G, and Smith MA. Distribution, levels, and activation of MEK1 in Alzheimer disease. J Neurochem 86: 136-142, 2003.
72. Zhu X, McShea A, Harris PLR, Raina AK, Castellani RJ, Funk JO, Shah S, Bowen R, Bowser R, Morelli L, Perry G, and Smith MA. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res 75: 698-703, 2004.
73. Zhu X, Raina AK, Perry G, and Smith MA. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol 3: 219-226, 2004.